{"id":"W2106275780","doi":"10.1200/jco.2009.22.3370","title":"Phase II Study of Preoperative Gefitinib in Clinical Stage I Non–Small-Cell Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Gefitinib; KRAS; Epidermal growth factor receptor; Internal medicine; Oncology; Lung cancer; Rash; Response Evaluation Criteria in Solid Tumors; Regimen; Stage (stratigraphy); Progressive disease; Cancer; Clinical trial; Phases of clinical research; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001183433,0.001344826,0.001854433,0.000272013,0.0003858412,0.0006969171,0.0006556476,0.001018799,0.001967562],"category_scores_gemma":[0.0008875284,0.0004162492,0.000956442,0.0002518832,0.0009852059,0.000512231,0.0002240085,0.002553483,0.0005658037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000984572,"about_ca_system_score_gemma":0.001566755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008308906,"about_ca_topic_score_gemma":0.002254605,"domain_scores_codex":[0.9995239,0.0002336117,0.00002202739,0.00006554336,0.0000477461,0.0001071057],"domain_scores_gemma":[0.9990596,0.0001501838,0.0001736268,0.00007700661,0.00005952681,0.0004800413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6966524,0.1000674,0.02281188,0.0007817419,0.001182,0.0005048616,0.000410085,0.0041567,0.07294391,0.0001948226,0.004127426,0.0961669],"study_design_scores_gemma":[0.3110847,0.6526186,0.02650276,0.00002459685,0.00024372,0.0003781414,0.00005723217,0.001559703,0.005990566,0.00008429481,0.001431221,0.00002441384],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965257,0.0008720146,0.0003449013,0.0002006111,0.00007947412,0.001058134,0.0003157608,0.00005648898,0.0005469362],"genre_scores_gemma":[0.9951378,0.0004802884,0.0007863434,0.0003295247,0.0000850886,0.00122871,0.001115322,0.0000145099,0.0008225214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001967562,"threshold_uncertainty_score":0.007143676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.118653774650175,"score_gpt":0.572227637953893,"score_spread":0.453573863303718,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}